drugset / Trial / NCT00761319
Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to compare two ophthalmic solutions in patients with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | 0.005 % | Topical |
| Subject | Travoprost | Other / unclassified | 0.004 % | Topical |